Oxford Sciences Innovation
Browse news and features about Oxford Sciences Innovation – the world’s largest university-partnered venture firm. Oxford Sciences Innovation (OSI) helps Oxford’s world-leading science moves out of the laboratory and onto the global stage. In partnership with the University of Oxford, OSI creates fundamental technology companies that are built on science.
-
AI imaging solutions company Ultromics raises $33m in Series B funding
Led by Blue Venture Fund, the new funding will accelerate Oxford-based Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes.
-
PepGen secures $112.5m financing to advance muscular dystrophy therapies
The funding round included existing investors RA Capital Management, Oxford Sciences Innovation (OSI) and CureDuchenne Ventures and a host of new investors.
-
Kadans acquires Sherard Building on The Oxford Science Park
The c.28,000 sq ft building, let in its entirety to the Oxford Science Innovation (OSI), was acquired from MRP, the property arm of construction firm McAleer & Rushe.
-
First Light Fusion installs UK’s biggest two-stage hyper-velocity gas gun
Weighing 25,000kg, the new 38mm gun fires a 100g projectile, which can reach a maximum velocity of 6.5km/s or 14,500mph – 20 times the speed of sound.
-
Oxford Endovascular raises $10m to develop its origami engineered medical device
The raise will enable the company to complete development work and gain first in-human data through an early feasibility clinical study.
-
Corporate co-working scheme piloted in Oxfordshire and Bucks
The Corporate Co-working Membership scheme will give businesses the chance to offer employee collaboration at a convenient workspace close to home.
-
Oxford-based biotech Theolytics raises $6.8m Series A round funding
The round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI).
-
Biotech start-up DJS Antibodies raises £6m in seed funding
The biotech start-up company based in Upper Heyford will use the funds to accelerate the development of its novel antibody therapeutics for inflammatory disease.
-
Therapeutics company PepGen raises $45m Series A funding
The funding round was led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor, University of Oxford and CureDuchenne.
-
Refeyn Closes Series A Funding Round
Oxford-based Refeyn, which develops instrumentation for the disruptive new life science technology mass photometry, has successfully completed its Series A funding round.
-
£1bn in funding shows strength of Science & Technology in Oxfordshire
Bidwells, the commercial property consultancy – has estimated that organisations within Oxfordshire’s Science & Tech community have raised over £1bn in funding to date during 2020.
-
Oxford Sciences Innovation announces sale of Base Genomics to Exact Sciences
Oxford Sciences Innovation (OSI) has announced the sale of its portfolio company, Base Genomics, to Exact Sciences for a total consideration of $410m.